September 2019 post
9/10/2019 12:26:48 PM
ESC Congress 2019 was an astonishing success: over 32000 visitors at a program spanning from Saturday Aug 31 to Wednesday Sept 4 and focused on the best and latest science with renowned leaders in cardiovascular medicine. Being the largest such gathering in the world, ESC displayed more than 500 sessions during the five-day conference.
It is one of the professional events I cannot afford to miss: it is exciting to be part of a congress that covers so many interesting topics in cardiology. Everything is here together – science, practice, exhibitions, interesting people. A unique opportunity to get connected with experts coming from all over the world and present original research. At ESC Congress, I had the opportunity to keep abreast of the latest news in cardiology and talk about the results of my own research to colleagues from many other countries: ESC Congress did definitely provide a stimulus for my further research and practical work in my practice.
Now – after such a great moment - I strongly suggest everyone to review the ESC365 Congress resources: slides, videos and abstracts from ESC 2019.
Among the highlights, a satellite symposium was held in “The HUB Duras” on Monday Sept 2 from 13:00 to 13:45 on “Inodilators in Acute and Advanced Heart Failure” (John T PARISSIS (Athens, Greece) and Francesco FEDELE (Roma, Italy), as chairs, while the lectures and discussions were held by Finn GUSTAFSSON (Copenhagen, Denmark), Veli-Pekka HARJOLA (Helsinki, Finland), yours truly Gerhard PÖLZL (Innsbruck, Austria), Josep COMIN-COLET (Hospitalet De Llobregat, Spain), Piergiuseppe AGOSTONI (Milan, Italy), and Carsten TSCHOEPE (Berlin, Germany).
As it regards the LEODOR study (“repetitive use of levosimendan in advanced heart failure patients”), an investigator meeting was held to discuss about the progress in initiation of the centers and enrollment of the patients.